|
|
|
Alzheimer Disease Clinical Trials |
|
Thank you for your interest in clinical trials for Alzheimer Disease
Please click "Search" to find Alzheimer Disease clinical trials and medical research studies.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 17 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use
additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- A Brief Study To Evalute The Safety, Tolerabiltiy, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease - NCT00988598-32608
Conditions: Alzheimer's Disease
Location: Gainesville, FL
- A Brief Study To Evalute The Safety, Tolerabiltiy, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease - NCT00988598-91206
Conditions: Alzheimer's Disease
Location: Glendale, CA
- A Comparison of Two Standard Therapies in the Management of Dementia With Agitation - NCT00208819-30329
Conditions: Senile Dementia, Alzheimer Type - Dementia, Alzheimer Type - Alzheimer Disease - Dementia
Location: Atlanta, GA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-02155
Conditions: Alzheimer's Disease
Location: Boston, MA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-02906
Conditions: Alzheimer's Disease
Location: Providence, RI
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-06360
Conditions: Alzheimer's Disease
Location: Norwich, CT
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-06510
Conditions: Alzheimer's Disease
Location: New Haven, CT
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-07724
Conditions: Alzheimer's Disease
Location: Eatontown, NJ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-08540
Conditions: Alzheimer's Disease
Location: Princeton, NJ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-08755
Conditions: Alzheimer's Disease
Location: Toms River, NJ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-08903
Conditions: Alzheimer's Disease
Location: New Brunswick, NJ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-10016
Conditions: Alzheimer's Disease
Location: New York, NY
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-10032
Conditions: Alzheimer's Disease
Location: New York, NY
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-10454
Conditions: Alzheimer's Disease
Location: Bronx, NY
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-14620
Conditions: Alzheimer's Disease
Location: Rochester, NY
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-27103
Conditions: Alzheimer's Disease
Location: Winston Salem, NC
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-27157
Conditions: Alzheimer's Disease
Location: Winston-Salem, NC
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-27607
Conditions: Alzheimer's Disease
Location: Raleigh, NC
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-27609
Conditions: Alzheimer's Disease
Location: Raleigh, NC
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-27710
Conditions: Alzheimer's Disease
Location: Durham, NC
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-32224
Conditions: Alzheimer's Disease
Location: Jacksonville, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-32806
Conditions: Alzheimer's Disease
Location: Orlando, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-33009
Conditions: Alzheimer's Disease
Location: Hallandale Beach, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-33143
Conditions: Alzheimer's Disease
Location: South Miami, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-33445
Conditions: Alzheimer's Disease
Location: Delray Beach, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-33613
Conditions: Alzheimer's Disease
Location: Tampa, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-34601
Conditions: Alzheimer's Disease
Location: Brooksville, FL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-35294
Conditions: Alzheimer's Disease
Location: Birmingham, AL
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-42003
Conditions: Alzheimer's Disease
Location: Paducah, KY
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-43210
Conditions: Alzheimer's Disease
Location: Columbus, OH
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-43623
Conditions: Alzheimer's Disease
Location: Toledo, OH
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-46202
Conditions: Alzheimer's Disease
Location: Indianapolis, IN
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-53226
Conditions: Alzheimer's Disease
Location: Milwaukee, WI
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-53562
Conditions: Alzheimer's Disease
Location: Middleton, WI
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-63104
Conditions: Alzheimer's Disease
Location: St Louis, MO
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-63108
Conditions: Alzheimer's Disease
Location: St. Louis, MO
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-74104
Conditions: Alzheimer's Disease
Location: Tulsa, OK
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-75390
Conditions: Alzheimer's Disease
Location: Dallas, TX
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-78757
Conditions: Alzheimer's Disease
Location: Austin, TX
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-80239
Conditions: Alzheimer's Disease
Location: Denver, CO
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-85004
Conditions: Alzheimer's Disease
Location: Phoenix, AZ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-85006
Conditions: Alzheimer's Disease
Location: Phoenix, AZ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-85351
Conditions: Alzheimer's Disease
Location: Sun City, AZ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-85381
Conditions: Alzheimer's Disease
Location: Peoria, AZ
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-89106
Conditions: Alzheimer's Disease
Location: Las Vegas, NV
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-90095
Conditions: Alzheimer's Disease
Location: Los Angeles, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-91403
Conditions: Alzheimer's Disease
Location: Sherman Oaks, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-92037
Conditions: Alzheimer's Disease
Location: La Jolla, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-92103
Conditions: Alzheimer's Disease
Location: San Diego, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-92108
Conditions: Alzheimer's Disease
Location: San Diego, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-92660
Conditions: Alzheimer's Disease
Location: Newport Beach, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-92845
Conditions: Alzheimer's Disease
Location: Garden Grove, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-93720
Conditions: Alzheimer's Disease
Location: Fresno, CA
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-97225
Conditions: Alzheimer's Disease
Location: Portland, OR
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-97239
Conditions: Alzheimer's Disease
Location: Portland, OR
- A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease - NCT00890890-98108
Conditions: Alzheimer's Disease
Location: Seattle, WA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-02115
Conditions: Alzheimer's Disease
Location: Boston, MA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-02903
Conditions: Alzheimer's Disease
Location: Providence, RI
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-06510
Conditions: Alzheimer's Disease
Location: New Haven, CT
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-10016
Conditions: Alzheimer's Disease
Location: New York, NY
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-10029
Conditions: Alzheimer's Disease
Location: New York, NY
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-10032
Conditions: Alzheimer's Disease
Location: New York, NY
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-14620
Conditions: Alzheimer's Disease
Location: Rochester, NY
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-15213
Conditions: Alzheimer's Disease
Location: Pittsburgh, PA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-19104
Conditions: Alzheimer's Disease
Location: Philadelphia, PA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-20007
Conditions: Alzheimer's Disease
Location: Washington, DC
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-20057
Conditions: Alzheimer's Disease
Location: Washington, DC
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-20060
Conditions: Alzheimer's Disease
Location: Washington, DC
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-21224
Conditions: Alzheimer's Disease
Location: Baltimore, MD
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-29406
Conditions: Alzheimer's Disease
Location: North Charleston, SC
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-29425
Conditions: Alzheimer's Disease
Location: Charleston, SC
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-30329
Conditions: Alzheimer's Disease
Location: Atlanat, GA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-32224
Conditions: Alzheimer's Disease
Location: Jacksonville, FL
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-33140
Conditions: Alzheimer's Disease
Location: Miami Beach, FL
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-33613
Conditions: Alzheimer's Disease
Location: Tampa, FL
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-37208
Conditions: Alzheimer's Disease
Location: Nashville, TN
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-40504
Conditions: Alzheimer's Disease
Location: Lexington, KY
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-40536
Conditions: Alzheimer's Disease
Location: Lexington, KY
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-44122
Conditions: Alzheimer's Disease
Location: Beachwood, OH
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-46202
Conditions: Alzheimer's Disease
Location: Indianapolis, IN
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-48109
Conditions: Alzheimer's Disease
Location: Ann Arbor, MI
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-49503
Conditions: Alzheimer's Disease
Location: Grand Rapids, MI
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-53705
Conditions: Alzheimer's Disease
Location: Madison, WI
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-53792
Conditions: Alzheimer's Disease
Location: Madison, WI
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-60611
Conditions: Alzheimer's Disease
Location: Chicago, IL
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-60612
Conditions: Alzheimer's Disease
Location: Chicago, IL
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-63108
Conditions: Alzheimer's Disease
Location: St. Louis, MO
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-75390
Conditions: Alzheimer's Disease
Location: Dallas, TX
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-77030
Conditions: Alzheimer's Disease
Location: Houston, TX
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-77098
Conditions: Alzheimer's Disease
Location: Houston, TX
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-84108
Conditions: Alzheimer's Disease
Location: Salt Lake City, UT
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-85006
Conditions: Alzheimer's Disease
Location: Phoenix, AZ
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-85351
Conditions: Alzheimer's Disease
Location: Sun City, AZ
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-89102
Conditions: Alzheimer's Disease
Location: Las Vegas, NV
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-90033
Conditions: Alzheimer's Disease
Location: Los Angeles, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-90095
Conditions: Alzheimer's Disease
Location: Los Angeles, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-92037
Conditions: Alzheimer's Disease
Location: La Jolla, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-92081
Conditions: Alzheimer's Disease
Location: Vista, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-92103
Conditions: Alzheimer's Disease
Location: San Diego, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-92121
Conditions: Alzheimer's Disease
Location: San Diego, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-92660
Conditions: Alzheimer's Disease
Location: Newport Beach, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-92697A
Conditions: Alzheimer's Disease
Location: Irvine, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-92697B
Conditions: Alzheimer's Disease
Location: Irvine, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-92697C
Conditions: Alzheimer's Disease
Location: Irvine, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-92868
Conditions: Alzheimer's Disease
Location: Orange, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-94117
Conditions: Alzheimer's Disease
Location: San Francisco, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-94121
Conditions: Alzheimer's Disease
Location: San Francisco, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-94143
Conditions: Alzheimer's Disease
Location: San Francisco, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-94304
Conditions: Alzheimer's Disease
Location: Palo Alto, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-94553
Conditions: Alzheimer's Disease
Location: Martinez, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-95817
Conditions: Alzheimer's Disease
Location: Sacramento, CA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-97201
Conditions: Alzheimer's Disease
Location: Portland, OR
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-98104
Conditions: Alzheimer's Disease
Location: Seattle, WA
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease - NCT00566397-98108
Conditions: Alzheimer's Disease
Location: Seattle, WA
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-01201
Conditions: Alzheimer Disease
Location: Pittsfield, MA
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-02914
Conditions: Alzheimer Disease
Location: East Providence, RI
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-08540
Conditions: Alzheimer Disease
Location: Princeton, NJ
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-13210
Conditions: Alzheimer Disease
Location: Syracuse, NY
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-14620
Conditions: Alzheimer Disease
Location: Rochester, NY
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-19401
Conditions: Alzheimer Disease
Location: Norristown, PA
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-33407
Conditions: Alzheimer Disease
Location: West Palm Beach, FL
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-33445
Conditions: Alzheimer Disease
Location: Delray Beach, FL
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-34601
Conditions: Alzheimer Disease
Location: Brooksville, FL
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-38018
Conditions: Alzheimer Disease
Location: Cordova, TN
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-40503
Conditions: Alzheimer Disease
Location: Lexington, KY
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-46260
Conditions: Alzheimer Disease
Location: Indianapolis, IN
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-53562
Conditions: Alzheimer Disease
Location: Middleton, WI
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-80218
Conditions: Alzheimer Disease
Location: Denver, CO
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-85006
Conditions: Alzheimer Disease
Location: Phoenix, AZ
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-90720
Conditions: Alzheimer Disease
Location: Los Alamitos, CA
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-91316
Conditions: Alzheimer Disease
Location: Encino, CA
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-92626
Conditions: Alzheimer Disease
Location: Costa Mesa, CA
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease - NCT00912288-92660
Conditions: Alzheimer Disease
Location: Newport Beach, CA
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-02903
Conditions: Alzheimer´s Disease
Location: Providence, RI
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-06510
Conditions: Alzheimer´s Disease
Location: New Haven, CT
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-10016
Conditions: Alzheimer´s Disease
Location: New York, NY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-10021
Conditions: Alzheimer´s Disease
Location: New York, NY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-10029
Conditions: Alzheimer´s Disease
Location: New York, NY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-10032
Conditions: Alzheimer´s Disease
Location: New York, NY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-13210
Conditions: Alzheimer´s Disease
Location: Syracuse, NY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-14620
Conditions: Alzheimer´s Disease
Location: Rochester, NY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-19104
Conditions: Alzheimer´s Disease
Location: Philadelphia, PA
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-20057
Conditions: Alzheimer´s Disease
Location: Washington, DC
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-20060
Conditions: Alzheimer´s Disease
Location: Washington, DC
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-29406
Conditions: Alzheimer´s Disease
Location: N. Charleston, SC
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-33140
Conditions: Alzheimer´s Disease
Location: Miami Beach, FL
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-33613
Conditions: Alzheimer´s Disease
Location: Tampa, FL
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-34243
Conditions: Alzheimer´s Disease
Location: Sarasota, FL
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-35294
Conditions: Alzheimer´s Disease
Location: Birmingham, AL
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-37067
Conditions: Alzheimer´s Disease
Location: Franklin, TN
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-38104
Conditions: Alzheimer´s Disease
Location: Memphis, TN
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-40536
Conditions: Alzheimer´s Disease
Location: Lexington, KY
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-44122
Conditions: Alzheimer´s Disease
Location: Beachwood, OH
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-52242
Conditions: Alzheimer´s Disease
Location: Iowa City, IA
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-53705
Conditions: Alzheimer´s Disease
Location: Madison, WI
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-55905
Conditions: Alzheimer´s Disease
Location: Rochester, MN
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-60611
Conditions: Alzheimer´s Disease
Location: Chicago, IL
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-63104
Conditions: Alzheimer´s Disease
Location: St. Louis, MO
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-66160
Conditions: Alzheimer´s Disease
Location: Kansas City, KS
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-75390
Conditions: Alzheimer´s Disease
Location: Dallas, TX
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-84108
Conditions: Alzheimer´s Disease
Location: Salt Lake City, UT
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-85006
Conditions: Alzheimer´s Disease
Location: Phoenix, AZ
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-85351
Conditions: Alzheimer´s Disease
Location: Sun City, AZ
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-85724
Conditions: Alzheimer´s Disease
Location: Tucson, AZ
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-89106
Conditions: Alzheimer´s Disease
Location: Las Vegas, NV
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-90033
Conditions: Alzheimer´s Disease
Location: Los Angeles, CA
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-92868
Conditions: Alzheimer´s Disease
Location: Orange, CA
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease - NCT00818662-97201
Conditions: Alzheimer´s Disease
Location: Portland, OR
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-02763
Conditions: Alzheimer's Disease
Location: West Yarmouth, MA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-07724
Conditions: Alzheimer's Disease
Location: Eatontown, NJ
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-07755
Conditions: Alzheimer's Disease
Location: Oakhurst, NJ
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-08755
Conditions: Alzheimer's Disease
Location: Toms River, NJ
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-13210
Conditions: Alzheimer's Disease
Location: Syracuse, NY
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-14127
Conditions: Alzheimer's Disease
Location: Orchard Park, NY
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-14211
Conditions: Alzheimer's Disease
Location: Buffalo, NY
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-14215
Conditions: Alzheimer's Disease
Location: Buffalo, NY
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-14226
Conditions: Alzheimer's Disease
Location: Amherst, NY
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-15009
Conditions: Alzheimer's Disease
Location: Beaver, PA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-15017
Conditions: Alzheimer's Disease
Location: Bridgeville, PA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-15241A
Conditions: Alzheimer's Disease
Location: Pittsburgh, PA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-15241B
Conditions: Alzheimer's Disease
Location: Upper St. Clair, PA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-15701
Conditions: Alzheimer's Disease
Location: Indiana, PA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-16127
Conditions: Alzheimer's Disease
Location: Grove City, PA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-16602
Conditions: Alzheimer's Disease
Location: Altoona, PA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-17254
Conditions: Alzheimer's Disease
Location: Scotland, PA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-19401
Conditions: Alzheimer's Disease
Location: Norristown, PA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-19707
Conditions: Alzheimer's Disease
Location: Hockessin, DE
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-23185
Conditions: Alzheimer's Disease
Location: Williamsburg, VA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-25304
Conditions: Alzheimer's Disease
Location: Charleston, WV
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-27103A
Conditions: Alzheimer's Disease
Location: Winston Salem, NC
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-27103B
Conditions: Alzheimer's Disease
Location: Winston-Salem, NC
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-27607
Conditions: Alzheimer's Disease
Location: Raleigh, NC
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-27612
Conditions: Alzheimer's Disease
Location: Raleigh, NC
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-28211
Conditions: Alzheimer's Disease
Location: Charlotte, NC
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-29118
Conditions: Alzheimer's Disease
Location: Orangeburg, SC
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-29406
Conditions: Alzheimer's Disease
Location: North Charleston, SC
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-29425
Conditions: Alzheimer's Disease
Location: Charleston, SC
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-29576
Conditions: Alzheimer's Disease
Location: Murrells Inlet, SC
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-29651
Conditions: Alzheimer's Disease
Location: Greer, SC
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-30308
Conditions: Alzheimer's Disease
Location: Atlanta, GA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-32114
Conditions: Alzheimer's Disease
Location: Daytona Beach, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-32117
Conditions: Alzheimer's Disease
Location: Daytona Beach, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-32127
Conditions: Alzheimer's Disease
Location: Port Orange, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-32541
Conditions: Alzheimer's Disease
Location: Destin, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-32547
Conditions: Alzheimer's Disease
Location: Fort Walton Beach, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-32806
Conditions: Alzheimer's Disease
Location: Orlando, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-32901
Conditions: Alzheimer's Disease
Location: Melbourne, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-33563
Conditions: Alzheimer's Disease
Location: Plant City, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-33606
Conditions: Alzheimer's Disease
Location: Tampa, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-33629
Conditions: Alzheimer's Disease
Location: Tampa, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-33709
Conditions: Alzheimer's Disease
Location: St. Petersburg, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-33713
Conditions: Alzheimer's Disease
Location: St Petersburg, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-33756
Conditions: Alzheimer's Disease
Location: Clearwater, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-33912
Conditions: Alzheimer's Disease
Location: Fort Myers, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-33952
Conditions: Alzheimer's Disease
Location: Port Charlotte, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-34102
Conditions: Alzheimer's Disease
Location: Naples, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-34205
Conditions: Alzheimer's Disease
Location: Bradenton, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-34471
Conditions: Alzheimer's Disease
Location: Ocala, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-34474
Conditions: Alzheimer's Disease
Location: Ocala, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-34601
Conditions: Alzheimer's Disease
Location: Brooksville, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-34731
Conditions: Alzheimer's Disease
Location: Fruitland Park, FL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-35476
Conditions: Alzheimer's Disease
Location: Northport, AL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-36608
Conditions: Alzheimer's Disease
Location: Mobile, AL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-37067
Conditions: Alzheimer's Disease
Location: Franklin, TN
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-37203
Conditions: Alzheimer's Disease
Location: Nashville, TN
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-37920
Conditions: Alzheimer's Disease
Location: Knoxville, TN
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-38654
Conditions: Alzheimer's Disease
Location: Olive Branch, MS
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-39232
Conditions: Alzheimer's Disease
Location: Flowood, MS
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-45227
Conditions: Alzheimer's Disease
Location: Cincinnati, OH
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-46140
Conditions: Alzheimer's Disease
Location: Greenfield, IN
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-46514
Conditions: Alzheimer's Disease
Location: Elkhart, IN
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-46805
Conditions: Alzheimer's Disease
Location: Fort Wayne, IN
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-47714
Conditions: Alzheimer's Disease
Location: Evansville, IN
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-54650
Conditions: Alzheimer's Disease
Location: La Crosse, WI
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-57105
Conditions: Alzheimer's Disease
Location: Sioux Falls,
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-58103
Conditions: Alzheimer's Disease
Location: Fargo, ND
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-58104
Conditions: Alzheimer's Disease
Location: Fargo, ND
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-59405
Conditions: Alzheimer's Disease
Location: Great Falls, MT
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-60007
Conditions: Alzheimer's Disease
Location: Elk Grove Village, IL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-60527
Conditions: Alzheimer's Disease
Location: Burr Ridge, IL
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-64114
Conditions: Alzheimer's Disease
Location: Kansas City, MO
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-65807
Conditions: Alzheimer's Disease
Location: Springfield, MO
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-66206
Conditions: Alzheimer's Disease
Location: Prairie Village, KS
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-67207
Conditions: Alzheimer's Disease
Location: Wichita, KS
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-70114
Conditions: Alzheimer's Disease
Location: New Orleans, LA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-70601
Conditions: Alzheimer's Disease
Location: Lake Charles, LA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-71105
Conditions: Alzheimer's Disease
Location: Shreveport, LA
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-72205
Conditions: Alzheimer's Disease
Location: Little Rock, AR
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-73112
Conditions: Alzheimer's Disease
Location: Oklahoma City, OK
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease - NCT00838110-75007
Conditions: Alzheimer's Disease
Location: Carrollton, TX
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|